http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101320802-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate | 2011-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101320802-B1 |
| titleOfInvention | Multi-Layered Tablets Containing Release-Controlled Safoacrylate Hydrochloride |
| abstract | The present invention (a) a rapid release containing safoglylate hydrochloride and fast-acting excipients; And (b) a controlled release tablet comprising a controlled release safoacrylate hydrochloride comprising a sustained release comprising safoacrylate hydrochloride, a hydrophilic polymer and an effervescent additive, or a controlled release sustained release comprising a safoacrylate hydrochloride, a hydrophilic polymer and a controlled release sustained release base. It is about. Multi-layered tablets containing controlled-release safoglylate hydrochloride according to the present invention are administered orally to give an immediate therapeutic effect, and the active ingredient maintains a constant concentration in plasma for a considerable time, so that the number of administrations is once a day. Not only can it be reduced, but as a result, drug compliance with patients can be increased, thereby increasing medication compliance. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109069435-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017155350-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019507795-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109069435-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101790286-B1 |
| priorityDate | 2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.